Skip to search formSkip to main contentSkip to account menu

Eylea

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
PURPOSE To investigate the effect of age on aflibercept (Eylea) response in macular edema secondary to treatment-naive diabetic… 
2019
2019
Originally approved in 2011, aflibercept is a vascular endothelial growth factor (VEGF) inhibitor. 
2018
2018
PurposeTo investigate the short-term effect of single intravitreal aflibercept injection on retrobulbar blood flow in patients… 
2018
2018
Aim: Treatment of exudative age-related macular degeneration by using vascular endothelial growth factor (VEGF) antagonists is… 
2016
2016
Background: We present an interesting case of bilateral retinitis pigmentosa (RP)-associated cystoid macular oedema that… 
2016
2016
Anti-VEGF Drugs Anti-VEGF drugs are used to treat retinal conditions such as the wet form of age-related macular degeneration… 
2014
2014
Purpose To evaluate the functional, anatomical, vascular flow, effects of intravitreal Aflibercept injections(IVT) for subretinal…